Cullinan Therapeutics, Inc.
CGEM- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001789972
In the last 90 days, Cullinan Therapeutics, Inc. insiders filed 0 open-market purchases and 3 sales; 183 institutions reported holding it in 13F filings for Q2 2026, worth $1.30B in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Cullinan Therapeutics, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 145
- +1 vs. Q2 2025
- Shares held
- 61.1M
- −1.53M (−2.4%) vs. Q2 2025
- Total value
- $362.2M
- −$109.3M (−23.2%) vs. Q2 2025
- New holders
- 27
- 57 more added
- Sold out
- 26
- 37 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CGEM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 183 | $1.30B |
| Q1 2026 | 174 | $931.0M |
| Q4 2025 | 153 | $653.8M |
| Q3 2025 | 145 | $362.2M |
| Q2 2025 | 144 | $471.4M |
| Q1 2025 | 149 | $489.6M |
| Q4 2024 | 147 | $798.8M |
| Q3 2024 | 137 | $1.09B |
| Q2 2024 | 135 | $1.10B |
| Q1 2024 | 113 | $670.8M |
| Q4 2023 | 113 | $375.6M |
| Q3 2023 | 106 | $344.0M |
| Q2 2023 | 106 | $397.3M |
| Q1 2023 | 103 | $329.5M |
| Q4 2022 | 97 | $397.7M |
| Q3 2022 | 100 | $474.7M |
| Q2 2022 | 89 | $481.7M |
| Q1 2022 | 82 | $386.3M |
| Q4 2021 | 75 | $559.7M |
| Q3 2021 | 66 | $762.3M |
| Q2 2021 | 71 | $828.5M |
| Q1 2021 | 70 | $1.30B |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Cullinan Therapeutics, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Qube Research & Technologies Ltd | 152,409 | $903.8K | 0.00% | +85,290+127.1% | Added |
| XTX Topco Ltd | 167,979 | $996.1K | 0.05% | +124,884+289.8% | Added |
| Wellington Management Group LLP | 168,131 | $997.0K | 0.00% | −17,952−9.6% | Reduced |
| Assenagon Asset Management S.A. | 177,685 | $1.05M | 0.00% | +167,623+1,665.9% | Added |
| Trexquant Investment LP | 187,618 | $1.11M | 0.01% | +68,276+57.2% | Added |
| UBS Group AG | 188,185 | $1.12M | 0.00% | −123,124−39.6% | Reduced |
| Jump Financial, LLC | 194,507 | $1.15M | 0.01% | +194,507 | New |
| AQR Capital Management LLC | 197,920 | $1.17M | 0.00% | +177,000+846.1% | Added |
| Nuveen, LLC | 215,595 | $1.28M | 0.00% | +34,910+19.3% | Added |
| Voss Capital, LLC | 221,473 | $1.31M | 0.08% | −30,244−12.0% | Reduced |
| Cubist Systematic Strategies, LLC | 222,318 | $1.32M | 0.02% | +222,318 | New |
| Algert Global LLC | 236,092 | $1.40M | 0.02% | +20,512+9.5% | Added |
| Barclays PLC | 251,110 | $1.49M | 0.00% | −17,357−6.5% | Reduced |
| Affinity Asset Advisors, LLC | 263,817 | $1.56M | 0.15% | 00.0% | Unchanged |
| Marshall Wace, LLP | 295,442 | $1.75M | 0.00% | −331,139−52.8% | Reduced |
| Jane Street Group, LLC | 300,885 | $1.78M | 0.00% | +252,002+515.5% | Added |
| Morgan Stanley | 400,154 | $2.37M | 0.00% | +158,062+65.3% | Added |
| Charles Schwab Investment Management Inc | 402,638 | $2.39M | 0.00% | −32,878−7.5% | Reduced |
| Northern Trust Corp | 447,267 | $2.65M | 0.00% | −5,936−1.3% | Reduced |
| Renaissance Technologies LLC | 529,408 | $3.14M | 0.00% | +194,883+58.3% | Added |
| Millennium Management LLC | 550,471 | $3.26M | 0.00% | +39,643+7.8% | Added |
| Bank of America Corp | 557,189 | $3.30M | 0.00% | −104,096−15.7% | Reduced |
| Deutsche Bank AG | 571,738 | $3.39M | 0.00% | +4,957+0.9% | Added |
| Twin Focus Capital Partners, LLC | 595,489 | $3.53M | 0.45% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 983,960 | $5.83M | 0.00% | +281,822+40.1% | Added |
| Tang Capital Management LLC | 1,121,138 | $6.65M | 0.26% | 00.0% | Unchanged |
| Nextech Invest, Ltd. | 1,141,145 | $6.77M | 1.03% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 1,183,821 | $7.02M | 0.00% | −92,717−7.3% | Reduced |
| Siren, L.L.C. | 1,193,410 | $7.08M | 0.28% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 1,295,320 | $7.68M | 0.00% | +15,824+1.2% | Added |
| VR Adviser, LLC | 1,379,965 | $8.18M | 0.46% | 00.0% | Unchanged |
| Franklin Resources Inc | 1,416,036 | $8.40M | 0.00% | −812,124−36.4% | Reduced |
| State Street Corp | 1,677,314 | $9.95M | 0.00% | +69,722+4.3% | Added |
| RTW Investments, LP | 1,705,960 | $10.1M | 0.12% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 1,923,855 | $11.4M | 0.27% | 00.0% | Unchanged |
| Citadel Advisors LLC | 1,984,407 | $11.8M | 0.01% | −629,286−24.1% | Reduced |
| Kynam Capital Management, LP | 2,302,172 | $13.7M | 1.02% | +206,174+9.8% | Added |
| Blue Owl Capital Holdings LP | 2,510,972 | $14.9M | 4.62% | +125,000+5.2% | Added |
| Deerfield Management Company, L.P. (Series C) | 2,927,013 | $17.4M | 0.27% | −928,539−24.1% | Reduced |
| Vanguard Group Inc | 2,943,325 | $17.5M | 0.00% | −76,775−2.5% | Reduced |
| BlackRock, Inc. | 4,169,962 | $24.7M | 0.00% | −47,971−1.1% | Reduced |
| BVF Inc | 5,750,683 | $34.1M | 1.38% | 00.0% | Unchanged |
| Lynx1 Capital Management LP | 5,766,090 | $34.2M | 6.96% | +1,365,248+31.0% | Added |
| MPM Oncology Impact Management LP | 7,648,268 | $45.4M | 7.42% | 00.0% | Unchanged |
| Colony Group, LLC | 3,498 | – | – | +3,498 | New |
| Patient Square Capital LP | 0 | $0 | 0.00% | −868,897−100.0% | Sold out |
| Rock Springs Capital Management LP | 0 | $0 | 0.00% | −668,233−100.0% | Sold out |
| Foresite Capital Management VI LLC | 0 | $0 | 0.00% | −594,025−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −139,660−100.0% | Sold out |
| NEOS Investment Management LLC | 0 | $0 | 0.00% | −42,692−100.0% | Sold out |
| Tema ETFs LLC | 0 | $0 | 0.00% | −42,692−100.0% | Sold out |
| HighVista Strategies LLC | 0 | $0 | 0.00% | −31,893−100.0% | Sold out |
| Nebula Research & Development LLC | 0 | $0 | 0.00% | −31,853−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −22,341−100.0% | Sold out |
| Martingale Asset Management L P | 0 | $0 | 0.00% | −20,932−100.0% | Sold out |
| Palumbo Wealth Management LLC | 0 | $0 | 0.00% | −17,008−100.0% | Sold out |
| Commonwealth Equity Services, LLC | 0 | $0 | 0.00% | −14,699−100.0% | Sold out |
| Voya Investment Management LLC | 0 | $0 | 0.00% | −14,661−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −13,988−100.0% | Sold out |
| Massar Capital Management, LP | 0 | $0 | 0.00% | −13,418−100.0% | Sold out |
| State of Wisconsin Investment Board | 0 | $0 | 0.00% | −11,173−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −11,129−100.0% | Sold out |
| Skopos Labs, Inc. | 0 | $0 | 0.00% | −3,665−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −2,115−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −1,495−100.0% | Sold out |
| Bessemer Group Inc | 0 | $0 | 0.00% | −436−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −295−100.0% | Sold out |
| Washington Trust Advisors, Inc. | 0 | $0 | 0.00% | −127−100.0% | Sold out |
| MAI Capital Management | 0 | $0 | 0.00% | −76−100.0% | Sold out |
| Larson Financial Group LLC | 0 | $0 | 0.00% | −56−100.0% | Sold out |
| Versant Capital Management, Inc | 0 | $0 | 0.00% | −23−100.0% | Sold out |